FINWIRES · TerminalLIVE
FINWIRES

Eni Unit Plenitude Closes $586 Million ACEA Deal, Adds 1.2 Million Customers

-- Eni (E) said Friday its unit Plenitude completed a roughly 500 million euro ($586 million) acquisition, adding about 1.2 million customers.

Plenitude, a subsidiary of Eni, finalized the purchase of full ownership in Acea Energia and a 50% stake in Umbria Energy, completing a transaction previously cleared by regulators.

The deal transfers around 1.2 million customers to Plenitude, though vulnerable electricity users were excluded and will remain under ACEA.

The total consideration is approximately 500 million euros, based on an enterprise value of 448 million euros, adjusted for the cash position as of Dec. 31, 2024, along with other agreed financial adjustments.

The structure also includes dividend-related adjustments of about 82 million euros paid to ACEA, as well as provisions tied to transaction timing and any potential financial leakages.

An additional earnout of up to 100 million euros may be paid depending on operating performance, with evaluation scheduled for completion by June 30, 2027.

ACEA is an Italy-based infrastructure group focused on water, energy, and environmental services, with 116 years of operations, leading Italy's water sector and expanding internationally, while emphasizing regulated assets and sustainability-driven growth.

Plenitude operates in 15+ countries with 5.8 gigawatts capacity and 11 million customers, targeting 15 gigawatts, 15 million users, and 30,000 EV charging points by 2030.

Price: $56.30, Change: $+0.62, Percent Change: +1.11%

Related Articles

Research

Research Alert: Hca: Share Repurchases Help Q1 Eps Meet Estimates Despite Volume Pressures

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:HCA Healthcare delivered Q1 2026 EPS of $7.15, in line with consensus and up 10.9% Y/Y, while revenue of $19.109B grew 4.3% and beat the $19.07B consensus estimate. Same-facility admissions rose 1.3%, though surgical volumes declined with inpatient and outpatient surgeries down 0.3% and 1.7%, respectively, reflecting softness in elective procedures and seasonal headwinds. Strong share repurchase activity of $1.571B during the quarter supported EPS growth despite volume pressures. Management reaffirmed 2026 guidance ranges, indicating confidence in navigating policy headwinds. Adjusted EBITDA margin compressed 50 bps to 19.9% due to challenging volumes and inflationary cost pressures, though operating cash flow surged 22% to $2.014B. We view the continued strong cash generation and $9.179B remaining share repurchase authorization as supportive of capital returns despite headwinds from ACA enhanced premium tax credit expirations and OBBBA Medicaid funding cuts.

$HCA
Research

Research Alert: CFRA Maintains Buy Opinion On Shares Of Intel Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our target price to $100 from $75, on a P/E of 33.3x our 2028 EPS, above peers/historical to reflect our view of upside to margins/estimates. After the better than expected Q1/Q2 guide, we lift our 2026 EPS to $1.05 from $0.70, 2027 to $1.40 from $1.30, and 2028 to $3.00 from $2.64. We expect INTC's revenue trajectory to benefit from greater content share in AI servers, where the CPU-to-accelerator ratio is moving from 1:8 back toward 1:4 or potentially parity, driven by inference, agentic AI, and physical AI workloads that are more CPU-intensive. This positions the Xeon franchise for strong, sustainable demand, with a product pipeline that is ramping the fastest in five years. Within the client segment, AI PCs are now over 60% of the client CPU mix. We are also encouraged by Intel Foundry momentum amid leading-edge wafer capacity shortages, with the Elon Musk Terafab partnership and multi-year long-term agreements with Google providing major endorsements. Intel 18A process yields are tracking well.

$INTC
Research

Research Alert: CFRA Keeps Hold Rating On Shares Of Bread Financial Holdings, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price to $96 from $79, 7.8x our 2027 EPS view vs. BFH's three-year historical forward P/E average of 6.2x and the peer average of 7.1x. We increase our 2026 EPS estimate to $11.30 from $9.70 and 2027's to $12.30 from $11.62, reflecting the company's significant Q1 earnings beat and the substantial impact of an accelerated share repurchase program. A key win from Q1 was the company's return to loan growth, reversing prior-period declines with a 2% Y/Y increase in end-of-period loans. This inflection was underpinned by robust consumer activity, with credit sales accelerating to 7% growth. Furthermore, credit metrics continued their gradual improvement, with the delinquency rate falling to 5.6% and the net loss rate decreasing to 7.3%. Management prudently maintained its 2026 outlook for low single-digit growth in both average loans and revenue, with net loss rate guidance of 7.2%-7.4%, a move we believe wisely accounts for ongoing macroeconomic uncertainty and geopolitical tensions.

$BFH